# OnCo record saw-palmetto (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/saw-palmetto/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "saw-palmetto" ;
  schema:name "Saw palmetto"@en ;
  schema:alternateName "Serenoa repens"@en, "Sabal"@en ;
  schema:description "Saw palmetto is widely taken for an enlarged prostate, with conflicting trial results. It does not change prostate-specific antigen levels and there is no evidence it treats prostate cancer. It has been linked to bleeding, including during an operation, and Memorial Sloan Kettering advises checking with a doctor before using it during radiotherapy."@en ;
  schema:url <https://onco.cc/technologies/saw-palmetto/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/integrative-medicine/herbs/saw-palmetto>, <https://www.cancer.gov/about-cancer/treatment/cam/hp/pc-spes-pdq> ;
  onco:status "phase-2" ;
  onco:tag "complementary", "supportive-care", "evidence:insufficient" ;
  onco:related <https://onco.cc/technologies/pomegranate-extract/>, <https://onco.cc/technologies/red-clover-isoflavones/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/integrative-oncology/>, <https://onco.cc/technologies/dietary-supplements-treatment-interactions/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-misinformation/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> .